Altai Protocol Library New Reference: Rituximab – Ibrutinib for Untreated Mantle Cell Lymphoma U. Darda Bayraktar, MD 2025-10-23
Altai Protocol Library New Reference: Neoadjuvant FOLFIRINOX vs. Chemoradiation for Pancreatic Cancer U. Darda Bayraktar, MD 2025-10-22
Altai Protocol Library New Indication: Lenvatinib + Pembrolizumab for Thymic Carcinoma U. Darda Bayraktar, MD 2025-10-22
Altai Protocol Library New Reference: Osimertinib with Platinum-Pemetrexed for Advanced EGFR-Mutated NSCLC U. Darda Bayraktar, MD 2025-10-21
Altai Protocol Library New Indication: Pembrolizumab with Platinum-5FU for Advanced Penile Cancer U. Darda Bayraktar, MD 2025-10-20
Altai Protocol Library New Reference: Lenvatinib + Pembrolizumab for Melanoma U. Darda Bayraktar, MD 2025-10-20
Altai Protocol Library New Reference: Nivolumab + Cabozantinib for 1st Line RCC U. Darda Bayraktar, MD 2025-10-19
Altai Protocol Library New Reference: Adjuvant Palbociclib for HR+ Breast Cancer U. Darda Bayraktar, MD 2025-10-18
Altai Protocol Library New Reference: Abemaciclib for Adjuvant Breast Cancer U. Darda Bayraktar, MD 2025-10-18
Altai Protocol Library New Reference: Alectinib for ALK-Positive Advanced NSCLC U. Darda Bayraktar, MD 2025-10-18
